Original Research
Published on 25 Jan 2023
Enhanced myocardial blood flow in ischemic cardiomyopathy by a slow-release synthetic prostacyclin agonist combined with coronary artery bypass grafting: The first human study in a Phase I/IIa clinical trial
in Clinical and Translational Cardiovascular Medicine
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1047666
- 2,598 views
- 3 citations


